Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1α with a Th2- associated expression pattern

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1411-1418

  Kodelja, Vitam ^a   Müller, Carola ^a   Politz, Oliver ^a   Hakij, Nahid ^a   Orfanos, Constantin E ^a   Goerdt, Sergij ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MACROPHAGE ACTIVATION ASSOCIATED CC CHEMOKINE 1; CHEMOKINE; COMPLEMENTARY DNA; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; SMOKING;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHEMOKINES, CC; CLONING, MOLECULAR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES, ALVEOLAR; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TH2 CELLS;

EID: 2642622567     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287.
2. Becker, S., and E. G. Daniel. 1990. Antagonistic effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell. Immunol. 129:351.
3. Te Velde, A. A., R. J. F. Huijbens, J. E. de Vries, and C. G. Figdor. 1990. IL-4 decreases FcγR membrane expression and FcγR-mediated cytotoxic activity of human monocytes. J. Immunol. 144:3046.
4. Cowan, H. B., S. Vick, J. T. Conary, and V. L. Shepherd. 1992. Dexamethasone upregulates mannose receptor activity by increasing mRNA levels. Arch. Biochem. Biophys. 296:314.
5. Conrad, D. J., H. Kuhn, M. Mulkins, E. Highland, and E. Sigal. 1992. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 89:217.
6. 2. Proc. Natl. Acad. Sci. USA 86:3803.
7. Hart, P. H., G. A. Whitty, D. R. Burgess, M. Croatto, and J. A. Hamilton. 1990. Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res. 9:147.
8. Cheung, D. L., P. H. Hart, G. F. Vitti, G. A. Whitty, and J. A. Hamilton. 1990. Contrasting effects of interferon-γ and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 71:70.
9. Goerdt, S., R. Bhardwaj, and C. Sorg. 1993. Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am. J. Pathol. 142:1409.
10. Landmann, R., A. E. Fisscher, and J.-P. Obrecht. 1992. Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages. J. Leukocyte Biol. 52:323.
11. Delespesse, G., and M. Sarfati. 1991. An update on human CD23 (FcεRII). FcεRII and IgE-BFs (soluble CD23) play an essential role in the regulation of human IgE synthesis. Clin. Exp. Allergy 21(Suppl. 1):153.
12. Goerdt, S., L. J. Walsh, G. F. Murphy, and J. S. Pober. 1991. Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells in normal human tissues. J. Cell Biol. 113:1425.
13. + dermal perivascular dendritic cells. Lab. Invest. 65:732.
14. Goerdt, S., G. Kolde, G. Bonsmann, K. Hamann, B. Czametzki, R. Andreesen, T. Luger, and C. Sorg. 1993. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J. Pathol. 170:421.
15. Zwadlo, G., R. Voegeli, K. Schulze-Osthoff, and C. Sorg. 1987. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp. Cell Biol. 55:295.
16. Wenzel, I., J. Roth, and C. Sorg. 1996. Identification of a novel surface molecule, RM 3/1, that contributes to the adhesion of glucocorticoid-induced human monocytes to endothelial cells. Eur. J. Immunol. 26:2758.
17. Goerdt, S., V. Kodelja, M. Schmuth, C. E. Orfanos, and C. Sorg. 1996. The mononuclear phagocyte-dendritic cell dichotomy: myths, facts, and a revised concept. Clin. Exp. Immunol. 105:1.
18. Kodelja, V., and S. Goerdt 1994. Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp. Dermatol. 3:257.
19. Topoll, H., G. Zwadlo, D. E. Lange, and C. Sorg. 1989. Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. J. Periodontal Res. 24:106.
20. Szekanecz, Z., G. K. Haines, T. R. Lin, L. A. Harlow, S. Goerdt, G. Rayan, and A. E. Koch. 1994. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia: their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 37:221.
21. -) in psoriatic dermis. Arch. Dermatol. Res. 288:757.
22. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russel, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243.
23. Kodelja, V., C. Müller, S. Tenorio, C. Schebesch, C. E. Orfanos, and S. Goerdt 1997. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197:478.
24. Schebesch, C., V. Kodelja, C. Müller, N. Hakij, C. E. Orfanos, and S. Goerdt. 1997 Alternatively activated macrophages do not co-stimulate, but actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T-cells in vitro. Immunology. In press.
25. Goerdt, S., F. Steckel, K. Schulze-Osthoff, H.-H. Hagemeier, E. Macher, and C. Sorg. 1989. Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelia, in skin vascular lesions and in vitro. Exp. Cell Biol. 57:185.
26. Sallusto,F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α. J. Exp. Med 179:1109.
27. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tools. J. Mol. Biol. 215:403.
28. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994 CLUSTAL W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673.
29. Peitsch, M. C. 1995. Protein modelling by email. Bio/Technology 13:658.
30. Peitsch, M. C. 1996. Promod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:274.
31. Wells, T. N. C., and M. C. Peitsch. 1997. The chemokine information source: identification and characterization of novel chemokines using the WorldWide-Web and expressed sequence tag databases. J. Leukocyte Biol. 61:545.
32. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595.
33. Schulz-Knappe, P., H.-J. Mägert, B. Dewald, M. Meyer, Y. Cetin, M. Kubbies, J. Tomeczkowski, K. Kirchhoff, M. Raida, K. Adermann, A. Kist, M. Reinecke, R. Sillard, A. Pardigol, M. Uguccioni, M. Baggiolini, and W.-G. Forssmann. 1996. HCC-1, a novel chemokine from human plasma. J. Exp. Med. 183:295.
34. Patel, V. P., B. L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo, B. Nardelli, V. Pippalla, S. Gentz, R. Thotakura, D. Parmelee, R. Gentz, and G. Garotta. 1997. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185:1163.
35. Rossi, D. L., A. P. Vicari, K. Franz-Bacon, T. K. McClanahan, and A. Zlotnik. 1997. Identification through bioinformatics of two new macrophage proinflammatory human chemokines, MIP-3a and MIP-3b. J. Immunol. 158:1033.
36. Orlofsky, A., E. Y. Lin, and M. B. Prystowsky. 1994. Selective induction of the b chemokine C10 by IL-4 in mouse macrophages. J. Immunol. 152:5084.
37. Poltorak, A. N., F. Bazzoni, I. I. Smimova, E. Alejos, P. Thompson, G. Luheshi, and N. Rothwell. 1995. MIP-1gamma: molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J. Inflamm. 45:207.
38. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S. Hensche Lima, Y. Li, B. Kreider, G. Garotta, M. Thelen, and M. Baggiolini. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379.
39. Chung, C.-w., R. M. Cooke, A. E. I. Proudfoot, and T. N. C. Wells. 1995. The three-dimensional structure of RANTES. Biochemistry 34:9307.
40. Clore, G. M., and A. M. Gronenborn. 1997. Three-dimensional structures of a and b chemokines. FASEB J. 9:57.
41. Wells, T. N. C., C. A. Power, M. Lusti-Narasimhan, A. J. Hoogewerf, R. M. Cooke, C.-w. Chung, M. C. Peitsch, and A. E. I. Proudfoot. 1996. Selectivity and antagonism of chemokine receptors. J. Leukocyte Biol. 59:53.
42. Standiford, T. J., S. L. Kunkel, J. M. Liebler, M. D. Burdick, A. R. Gilbert, and R. M. Strieter. 1993. Gene expression of macrophage inflammatory protein-1a from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 9:192.
43. Berkman, N., M. John, G. Roesems, P. Jose, P. J. Barnes, and K. F. Chung. 1996. Interleukin 13 inhibits macrophage inflammatory protein-1a production from human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 15:382.
44. Berkman, N., P. J. Jose, T. J. Williams, T. J. Schall, P. J. Barnes, and K. F. Chung. 1995. Corticosteroid inhibition of macrophage inflammatory protein-1a in human monocytes and alveolar macrophages. Am. J. Physiol. 269:1443.
45. Calandra, T., J. Bernhagen, C. N. Metz, L. A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 376:68.
46. Peters, J. H., R. Gieseler, B. Thiele, and F. Steinbach. 1996. Dendritic cells: from ontogenetic orphans to myelomonocytic descendents. Immunol. Today 17:273.
47. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, K. B. Bacon, and C. G. Figdor. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
48. Mommaas, A. M., A. Tan, A. A. Mulder, R. Jordens, J. J. M. Onderwater, J. W. Drijfhout, D. Verwoerd, T. H. M. Ottenhof, P. H. Kluin, A. Tulp, J. J. Neefjes, and F. Koning. 1997. In contrast to human blood derived dendritic cells, epidermal Langerhans cells do not employ the mannose receptor endocylosis pathway. J. Invest. Dermatol. 109:261.
49. Poulter, L. W., G. Janossy, C. Power, S. Sreenan, and C. Burke. 1994. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol. Today 15:258.
50. Fireman, E. M., S. B. Efraim, J. Greif, S. Kivity, and M. R. Topilsky. 1988. Suppressor cell activity of human alveolar macrophages in interstitial lung diseases. Clin. Exp. Immunol. 73:111.
51. Geertsma, M. F., W. L. Teeuw, P. H. Nibbering, and R. van Furth. 1994. Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-γ. Immunology 82:450.
52. Holt, P. G., M. A. Schon-Hegard, and J. Oliver. 1988. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat: regulation of antigen presentation activity by endogenous macrophage populations. J. Exp. Med. 167:262.
53. Gao, J.-L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
54. Liao, F., G. Alkhatib, K. W. C. Peden, G. Sharma, E. A. Berger, and J. M. Farber. 1997. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:2015.
55. Raport, C. J., V. L. Schweickart, D. Chantry, R. L. J. Eddy, T. Shows, R. Godiska, and P. W. Gray. 1996. New members of the chemokine receptor gene family. J. Leukocyte Biol. 59:18.